HUP0003647A3 - Bisethers of 1-oxa, aza and thianaphthalen-2-ones, their use for producing medicaments, the medicaments and their intermediates - Google Patents

Bisethers of 1-oxa, aza and thianaphthalen-2-ones, their use for producing medicaments, the medicaments and their intermediates

Info

Publication number
HUP0003647A3
HUP0003647A3 HU0003647A HUP0003647A HUP0003647A3 HU P0003647 A3 HUP0003647 A3 HU P0003647A3 HU 0003647 A HU0003647 A HU 0003647A HU P0003647 A HUP0003647 A HU P0003647A HU P0003647 A3 HUP0003647 A3 HU P0003647A3
Authority
HU
Hungary
Prior art keywords
medicaments
thianaphthalen
bisethers
aza
oxa
Prior art date
Application number
HU0003647A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of HUP0003647A2 publication Critical patent/HUP0003647A2/hu
Publication of HUP0003647A3 publication Critical patent/HUP0003647A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
HU0003647A 1997-09-24 1998-09-24 Bisethers of 1-oxa, aza and thianaphthalen-2-ones, their use for producing medicaments, the medicaments and their intermediates HUP0003647A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US93711997A 1997-09-24 1997-09-24
US99015097A 1997-12-12 1997-12-12
US10411498A 1998-06-25 1998-06-25
PCT/FI1998/000755 WO1999015523A1 (fr) 1997-09-24 1998-09-24 Bisethers de 1-oxa, aza et thianaphtalene-2-one inhibiteurs du phospholambane

Publications (2)

Publication Number Publication Date
HUP0003647A2 HUP0003647A2 (hu) 2001-08-28
HUP0003647A3 true HUP0003647A3 (en) 2002-12-28

Family

ID=27379660

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003647A HUP0003647A3 (en) 1997-09-24 1998-09-24 Bisethers of 1-oxa, aza and thianaphthalen-2-ones, their use for producing medicaments, the medicaments and their intermediates

Country Status (18)

Country Link
EP (1) EP1017691A1 (fr)
JP (1) JP2003525838A (fr)
KR (1) KR20010015607A (fr)
CN (1) CN1143857C (fr)
AU (1) AU735729B2 (fr)
BR (1) BR9813216A (fr)
CA (1) CA2304849A1 (fr)
EA (1) EA003084B1 (fr)
EE (1) EE04494B1 (fr)
HU (1) HUP0003647A3 (fr)
ID (1) ID24373A (fr)
IL (1) IL134662A0 (fr)
NO (1) NO20001569L (fr)
NZ (1) NZ503044A (fr)
PL (1) PL339493A1 (fr)
SK (1) SK3902000A3 (fr)
TR (1) TR200000764T2 (fr)
WO (1) WO1999015523A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7026491B2 (en) 2000-07-21 2006-04-11 Chugai Seiyaku Kabushiki Kaisha Coumarin derivatives useful as TNFα inhibitors
AU2002226634B2 (en) * 2001-03-30 2007-01-25 Pfizer Products Inc. Pyridazinone aldose reductase inhibitors
US7572910B2 (en) 2003-02-20 2009-08-11 Pfizer, Inc. Pyridazinone aldose reductase inhibitors
FR2970964B1 (fr) * 2011-01-28 2013-12-13 Univ Claude Bernard Lyon Nouveaux derives d'azacoumarines presentant une activite inhibitrice des pompes mdr

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2543945A1 (de) * 1975-10-02 1977-04-21 Troponwerke Gmbh & Co Kg 2-benzopyranonderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
GB8529362D0 (en) * 1985-11-28 1986-01-02 Pfizer Ltd Quinolone cardiac stimulants
GB8630702D0 (en) * 1986-12-23 1987-02-04 Wellcome Found Quinoline compound
DK391189A (da) * 1988-08-10 1990-02-11 Otsuka Pharma Co Ltd Carbostyrilderivater
CA2022236A1 (fr) * 1989-07-31 1991-02-01 Hiroaki Yanagisawa Derives de coumarin, leur preparation et leur utilisation pour le traitement des troubles cerebrovasculaires
DE4337906A1 (de) * 1993-11-08 1995-05-11 Cassella Ag Verwendung von Cumarinderivaten

Also Published As

Publication number Publication date
BR9813216A (pt) 2000-08-29
AU9350898A (en) 1999-04-12
EE04494B1 (et) 2005-06-15
CN1271357A (zh) 2000-10-25
EE200000179A (et) 2001-04-16
PL339493A1 (en) 2000-12-18
HUP0003647A2 (hu) 2001-08-28
ID24373A (id) 2000-07-13
CN1143857C (zh) 2004-03-31
EA003084B1 (ru) 2002-12-26
TR200000764T2 (tr) 2001-03-21
IL134662A0 (en) 2001-04-30
AU735729B2 (en) 2001-07-12
JP2003525838A (ja) 2003-09-02
NO20001569D0 (no) 2000-03-24
NO20001569L (no) 2000-03-24
NZ503044A (en) 2001-08-31
KR20010015607A (ko) 2001-02-26
EP1017691A1 (fr) 2000-07-12
CA2304849A1 (fr) 1999-04-01
SK3902000A3 (en) 2000-12-11
WO1999015523A1 (fr) 1999-04-01
EA200000352A1 (ru) 2000-10-30

Similar Documents

Publication Publication Date Title
HK1025096A1 (en) Disubstituted bicyclic heterocycles, their production and use as medicaments
HK1028769A1 (en) 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
HU9802422D0 (en) Substituted isoquinoline-3-carboxamide derivatives, process for producing them and their medical use
HUP9901478A3 (en) Carboline derivatives, their use, production thereof and medicaments containing the same
HUP9904204A3 (en) Naphthyridine derivatives, medicaments e.g. for asthma therapy containing them and intermediates
AU2498597A (en) New benzazepine derivatives, medicaments containing the same and their use to prepare medicaments
HRP960365B1 (en) New medicaments and the use thereof
HU9802224D0 (en) Pyrazol derivatives, process for producing them and their use as medicament
HK1078561A1 (en) Novel compounds, their use and preparation
HUP9802807A3 (en) 1,3,8-triazo-spiro[4,5]decan-4-on derivatives, their use, production thereof and medicaments containing the same
HU9802132D0 (en) Biphenyl-sulfonyl-cyanamides, process for producing them and their medical use
HUP9901376A3 (en) 1-methylcarbapenem derivatives, their use, production thereof and medicaments containing the same
IL134572A0 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6- methano-3-benzazocine-10-oles, methods for the production and use thereof as medicaments
HUP0103387A3 (en) Quinazoline derivatives preparation thereof, medicament containing them and their intermediates
HUP9902311A3 (en) New triazolopurines, method of preparing them and their use as drugs
HUP9600665A3 (en) Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
IL133597A0 (en) New combination of antiasthma medicaments
HUP9903715A3 (en) 25-hydroxy-16-ene-26,27-bishomo-cholecalciferols, their use and medicaments containing them
ZA97872B (en) Use of pyrolidine derivatives for the manufacture of medicaments.
HUP0003647A3 (en) Bisethers of 1-oxa, aza and thianaphthalen-2-ones, their use for producing medicaments, the medicaments and their intermediates
HU9800472D0 (en) New benzoxazinedion derivatives, process for producing them and use of them
NZ295656A (en) Substituted tetracyclic azepine derivatives, medicaments and intermediates
AU7760098A (en) New benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments
IL133242A0 (en) 5-Naphthalene-1-yl-1,3-dioxane derivatives their preparation and their therapeutic application
GB9619085D0 (en) Combined medicaments,their manufacture and use